Curcumin and Berberine Arrest Maturation and Activation of Dendritic Cells Derived from Lupus Erythematosus Patients.

Amin Reza NikpoorMahmoud MahmoudiAbbas Shapouri-MoghaddamZahra RezaieyazdiSamaneh MollazadehNafiseh TabasiAtena MansouriReyhane Modarres MoghadamAmir Abbas MomtaziSoran K NajmaldinRamiar Kamal KhederSeyed-Alireza Esmaeili

Published in: Current molecular pharmacology (2024)

CUR and BBR could arrest DC maturation and develop a tolerogenic DC phenotype that subsequently promoted the expression of inhibitory cytokines and reduced the secretion of proinflammatory markers.

Keyphrases

dendritic cells
end stage renal disease
regulatory t cells
immune response
ejection fraction
poor prognosis
newly diagnosed
systemic lupus erythematosus
cell cycle
chronic kidney disease
peritoneal dialysis
disease activity
rheumatoid arthritis
binding protein
cell proliferation
long non coding rna